Showing 641-650 of 10608 results for "".
Practice Cost Savings, Part IV: Banking
https://practicaldermatology.com/topics/practice-management/practice-cost-savings-part-iv-banking/21520/Evaluation and re-evaluation of banking services and relationships is one of the essential elements of any practice.Practice Cost Savings, Part III: Technology
https://practicaldermatology.com/topics/practice-management/practice-cost-savings-part-iii-technology/21525/From health records to IT, technology presents practices with unique challenges and opportunities for savings.Update on NSAIDs and Skin Cancer Prevention
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-nsaids-and-skin-cancer-prevention/21602/As more data point to protection against melanoma and NMSC, clinical implications are still limited.Cosmetics Challenge: Six Strategies for Scientific Skincare, Part 2 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-six-strategies-for-scientific-skincare-part-2-of-2/21934/Clinicians who are familiar with scientifically proven skincare ingredients, knowledgeable about formulations, and adept at combining topical products can help patients achieve or maintain cosmetic rejuvenation goals.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.Meet the Moys: Father and Daughter Dermatologists Reflect on the Specialty
https://practicaldermatology.com/topics/feature/moy-father-daughter-reflect-on-dermatology-specialty/26578/Meet the Moys: Father and Daughter Dermatologists Reflect on the SpecialtyTest Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/verrucous-psoriasis-a-rare-variant-refractory-to-topical-steroids/29204/In this case study, researchers present a patient with VP of the dorsal fingers that was initially diagnosed as psoriasis and treated with multiple topical steroids. Ultimately, the patient was refractory to steroid topical therapy and required consideration of alternative treatments for definitiveBimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.Addressing the Relationship Between Depression and Skin Disease
https://practicaldermatology.com/topics/general-topics/PD1208_03-php/22601/Dermatologists aren't expected to be psychotherapists, but they must be prepared to refer high-risk patients and to offer therapeutic support and understanding to others.